Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope

This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV‐negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

Detalles Bibliográficos
Autores principales: Kathrotiya, Manthan, Radhakrishnan, Vivek S, Bhave, Saurabh J, Kumar, Jeevan, Roychowdhury, Mita, Arun, Indu, Das, Jayanta, Chandy, Mammen, Nair, Reena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869339/
https://www.ncbi.nlm.nih.gov/pubmed/33598263
http://dx.doi.org/10.1002/ccr3.3673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869339/
https://www.ncbi.nlm.nih.gov/pubmed/33598263
http://dx.doi.org/10.1002/ccr3.3673

Ejemplares similares